Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7751–7800 of 34744
On August 5, 2024, Tang Siu Fung notified Blue Print Global, Inc. (“Blue Print”), a British Virgin Islands company and a wholly owned subsidiary of the Company of his resignation as the sole director of Blue Print.
On August 7, 2024, GEX Management, Inc. (the “Company”) announced that Joseph Frontiere will resign as a Board Director of GEX Management effective immediately.
On August 5, 2024, Stacy D. Nieuwoudt notified Independence Contract Drilling, Inc. (the “Company”) of her decision to resign effective August 16, 2024, from the Board of Directors.
the Board elected Mr. Britton Smith, currently our President, as a Class I director of the Company effective August 7, 2024, to fill the vacancy created by the prior resignation of Mr. Gurminder Bedi.
the Board increased the size of the Board from ten to eleven members and appointed Mr. Wacksman to fill the vacancy created.
On August 1, 2024, Samsara Inc. (the “Company”) appointed Alyssa Henry to its Board of Directors (the “Board”), effective August 4, 2024.
the Board also approved the appointment of Mr. Gupta to the Board, effective as of the Effective Date.
On August 1, 2024, Shaw Joseph notified European Wax Center, Inc. (the “Company”) that he would be resigning from the Company’s Board of Directors (“the Board”), effective immediately.
Following Mr. Joseph’s resignation, on August 1, 2024, the Board appointed Julia Hunter as a director of the Company to fill the vacancy on the Board, effective immediately.
On August 1, 2024, the Company’s Board of Directors (the “Board”) elected Adam Stewart as a director
Accepting the voluntary resignation of Heinrich Dreismann from the Board effective August 1, 2024
Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024
Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024
In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.
On August 5, 2024, the Board of Directors of ALX Oncology Holdings Inc. (the “Company”) appointed Alan Sandler, M.D. to serve as a Class III director of the Board of Directors of the Company (the “Board”) for a term expiring at the 2026 annual meeting of stockholders
In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.
effective August 1, 2024, Jonathan Ireland has resigned from the Company’s Board of Directors
Upon recommendation of the Governance Committee, and effective as of August 1, 2024 (the “Effective Date”), Mr. Silva was appointed to the Board as the SPV’s designee to fill the vacancy created by Mr. Hoffman’s resignation.
Olav Bergheim and James L. Cox were appointed as Class I directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
Orly Mishan and Shahram Moaddeb were appointed as Class II directors
Olav Bergheim and James L. Cox were appointed as Class I directors
Orly Mishan and Shahram Moaddeb were appointed as Class II directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
On August 6, 2024, the Nominating and Corporate Governance Committee of the Board nominated and the Board appointed Ms. Jia Yang as a vice president of the Company and as a director of the Board to fill the vacancy resulting from Mr. Haotian Song’s resignation.
On July 31, 2024, Mr. Haotian Song resigned from his position as a vice president of Singularity Future Technology Ltd. (the “ Company ”) and as a director of the board of directors of the Company (the “ Board ”).
On July 31, 2024, in connection with the IPO, Mr. Frederick Arnold and Mr. Benjamin Fader-Rattner were appointed to the board of directors of the Company
On July 31, 2024, in connection with the IPO, Mr. Frederick Arnold and Mr. Benjamin Fader-Rattner were appointed to the board of directors of the Company
the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board, effective August 5, 2024.
the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board, effective August 5, 2024.
Jerry Lewin resigned from his position as a member of the board of directors of the company on August 2, 2024, effective immediately.
On August 1, 2024, the Board of Trustees (the “Board”) of Nuveen Churchill Private Credit Fund (the “Company”) voted to increase the size of the Board from four (4) trustees to (5) trustees, and appointed Sarah Smith as a trustee effective August 1, 2024, to serve in such position until her successor is duly selected and qualified.
Effective August 1, 2024, Elizabeth Buchanan and Stephen Bowman were elected to the Board of Directors of Commonwealth Edison Company.
Effective August 1, 2024, Elizabeth Buchanan and Stephen Bowman were elected to the Board of Directors of Commonwealth Edison Company.
Lawrence W. Stranghoener provided notice to the Company that he does not intend to run for re-election to the Board at the Annual Meeting of Shareowners to be held in October 2024. He will retire from the Board at the end of that meeting.
On August 5, 2024, the Board of Directors (the “Board”) of PVH Corp. (the “Company”) appointed Kate Gulliver , 42, to the Board, effective immediately.
Appointment of New Director Effective July 31, 2024, the Board of Directors (the “Board”) of Johnson Controls International plc (the "Company") increased the size of the Board to 13 directors in accordance with its Memorandum and Articles of Association and appointed Patrick K . Decker to serve as a member of the Company’s Board
On August 1, 2024, Dr. Susan Altschuller notified Mural Oncology plc (the “Company”) of her decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees of the Board on which she serves, effective as of September 1, 2024.
the Board expanded its size from 11 directors to 12 directors and appointed Ms. Mikel A. Durham, former chief executive officer of American Seafoods Group, as a director, effective August 12, 2024.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
On July 30, 2024, the board of directors (the “Board”) of the Company appointed Charles McWherter, Ph.D. as a member of the Board.
On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.
On August 2, 2024, Gregory D. Ethridge resigned from the Board of Directors (the "Board") of Hennessy Capital Investment Corp. VI (the “Company”), effective immediately.
On August 4, 2024, the Company’s board of directors (“Board”) elected Daniel Wolf to serve as a director of the Company effective August 5, 2024, until his successor is elected and qualified, or sooner in the event of his death, resignation or removal.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.